Savara P/CF Ratio 2011-2026 | SVRA

Annual P/CF Ratio Savara

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-11.6	-11.7	-18.1	-8.84	-4.14	-2.14	-2.54	-6.32	-7.13	-0.829	-1.96	-2.16	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.829	-18.1	-6.45

P/CF Ratio of other stocks in the Biotechnology industry

Issuer	P/CF Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.654	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-94.9	$ 3.6	1.34 %	$ 8.66 B	Australia
Aytu BioScience AYTU	-8.14	$ 2.66	-	$ 16.7 M	USA
BioNTech SE BNTX	70.7	$ 91.28	-	$ 27.2 B	Germany
I-Mab IMAB	-0.266	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	11.6	-	-	$ 40.3 B	USA
Genfit SA GNFT	1.68 K	-	2.54 %	$ 160 B	France
Burford Capital Limited BUR	11.6	$ 4.48	-	$ 736 M	Britain
Biophytis SA BPTS	-23.1	-	-13.47 %	$ 169 M	France
Cerus Corporation CERS	102	$ 1.85	-	$ 353 M	USA
Midatech Pharma plc MTP	-13.2	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.88	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	-1.2	-	-24.86 %	$ 820 K	USA
Coherus BioSciences CHRS	-1.63	$ 1.67	-	$ 196 M	USA
Celldex Therapeutics CLDX	-9.67	$ 31.37	-	$ 2.08 B	USA
CollPlant Biotechnologies Ltd. CLGN	-2	$ 0.44	-	$ 5.04 M	Israel
Advaxis ADXS	-0.0633	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	-0.826	-	-	$ 86.2 M	USA
CNS Pharmaceuticals CNSP	-0.0767	$ 2.32	-	$ 1.03 M	USA
Институт стволовых клеток человека ISKJ	-89	-	-	-	Russia
Catalyst Pharmaceuticals CPRX	14.6	$ 24.98	-	$ 3.05 B	USA
Corbus Pharmaceuticals Holdings CRBP	-1.97	$ 10.14	-	$ 135 M	USA
Cardiff Oncology CRDF	-3.07	$ 1.58	-	$ 106 M	USA
Curis CRIS	-0.348	$ 0.53	-	$ 6.98 M	USA
Crinetics Pharmaceuticals CRNX	-10.9	$ 37.7	-	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	-12.7	$ 49.15	-	$ 4.42 B	Schweiz
Aeterna Zentaris AEZS	-4.82	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.0018	-	-10.17 %	$ 12.2 K	USA
CytomX Therapeutics CTMX	-12.3	$ 4.4	-	$ 607 M	USA
Citius Pharmaceuticals CTXR	-0.859	$ 0.86	-	$ 5.79 M	USA
Aeglea BioTherapeutics AGLE	-4.6	-	-	$ 1.01 B	USA
Cue Biopharma CUE	-1.35	$ 0.18	-	$ 17.1 M	USA
Applied Genetic Technologies Corporation AGTC	-0.64	-	-	$ 26.5 M	USA
DBV Technologies S.A. DBVT	-23.3	$ 20.36	-	$ 2.84 B	France
AIkido Pharma AIKI	-1.17	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	-0.0645	-	-45.71 %	$ 1.2 M	Canada
Denali Therapeutics DNLI	-8.74	$ 19.38	-	$ 3.19 B	USA
Dyadic International DYAI	-5.52	$ 0.87	-2.8 %	$ 31.5 M	USA
Akero Therapeutics AKRO	-14.1	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-4.82	-	-	$ 867 M	Germany
Akari Therapeutics, Plc AKTX	-765	$ 3.54	-	$ 238 B	Britain
Akouos AKUS	-2.7	-	0.23 %	$ 488 M	USA
Entera Bio Ltd. ENTX	-2.93	$ 1.19	-	$ 55.5 M	Israel
Equillium EQ	-5.19	$ 2.01	-	$ 115 M	USA
Allakos ALLK	-0.976	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	-2.48	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	77.9	$ 330.34	-	$ 43.3 B	USA
Alpine Immune Sciences ALPN	-6.14	-	-	$ 2.17 B	USA
Fate Therapeutics FATE	-1.76	$ 1.19	-	$ 141 M	USA
Aileron Therapeutics ALRN	-1.71	-	10.36 %	$ 9.8 M	USA